Corteva Resultados de beneficios anteriores
Pasado controles de criterios 3/6
Los beneficios de Corteva han disminuido a una tasa media anual de -6.6%, mientras que en la industria Chemicals los beneficios disminuyeron en un 3.8% anualmente. Los ingresos han ido creciendo a una tasa media de 2.6% al año. La rentabilidad financiera de Corteva es de 5.1%, y sus márgenes netos son de 7%.
Información clave
-6.62%
Tasa de crecimiento de los beneficios
-4.49%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 12.93% |
| Tasa de crecimiento de los ingresos | 2.62% |
| Rentabilidad financiera | 5.13% |
| Margen neto | 7.00% |
| Última actualización de beneficios | 31 Mar 2026 |
Actualizaciones de resultados anteriores recientes
Recent updates
Actualización del análisis • Apr 27
CTVA: Fair Value View Weighs Crop Protection Uncertainty And Planned SpinCo Separation
Corteva's analyst price target has increased by about $2, as analysts cite updated earnings models, a revised fair value of $86.05, a slightly adjusted discount rate, and modest changes to revenue growth, profit margin, and future P/E assumptions. Analyst Commentary Street research on Corteva has been active, with several price target revisions and a mix of ratings changes that give you both supportive and cautious signals to weigh.Actualización del análisis • Apr 13
CTVA: Fair Value View Balances Crop Protection Risks And Upcoming SpinCo Separation
The analyst price target for Corteva has moved modestly higher to align with a fair value estimate of about $84, as analysts factor in updated earnings models, slightly adjusted revenue growth and profit margin assumptions, and recent price target changes across several firms. Analyst Commentary Recent Street research on Corteva shows a mix of higher price targets and a few rating downgrades, so you are seeing both optimism and caution reflected in the current analyst debate.Actualización del análisis • Mar 28
CTVA: Crop Protection Uncertainty And SpinCo Separation Will Shape Future Risk Balance
The analyst price target for Corteva has been nudged higher, with a modest fair value uplift to $83.95 as analysts balance a series of recent target increases from multiple firms against more cautious views tied to softer crop protection trends. Analyst Commentary Recent research on Corteva reflects a split view, with several firms lifting price targets while others turn more cautious on near term fundamentals, especially in crop protection.Actualización del análisis • Mar 12
CTVA: Mixed Crop Protection Outlook And New SpinCo Plan Will Shape Risk Balance
The analyst price target for Corteva edges higher to $83.33 from $82.76, as analysts factor in slightly firmer long term revenue growth and profit margins, while balancing more cautious views on crop protection trends and a modestly lower discount rate. Analyst Commentary Recent research on Corteva reflects a split view, with several firms lifting price targets while others turn more cautious on execution in crop protection.Actualización del análisis • Feb 26
CTVA: Sector Uncertainty And New Ventures Will Shape Forward Risk Balance
Corteva's analyst fair value estimate has edged up to $82.76 from $82.05 as analysts refine their models and price targets following recent earnings updates and a broad wave of upward target revisions across the Street. Analyst Commentary Recent Street research around Corteva reflects an active debate, with several firms adjusting price targets and a mix of upgrades and downgrades around the latest earnings update.Actualización del análisis • Feb 11
CTVA: Mixed Sector Backdrop And New Ventures Will Shape Future Prospects
Corteva's analyst fair value estimate has increased to $82.05 from $78.43 as analysts factor in slightly stronger revenue growth assumptions, a higher future P/E multiple, and a modestly lower discount rate, even as projected profit margins are trimmed. Analyst Commentary Recent Street research on Corteva is mixed, with several bullish analysts lifting price targets while a few high profile firms turn more cautious.Actualización del análisis • Jan 26
CTVA: Seed And Crop Protection Split Will Shape Balanced Future Prospects
Narrative Update Analysts have modestly raised their price expectations for Corteva, with the updated fair value estimate moving by about US$0.48 per share. This reflects slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E, and is supported by recent target increases from several firms.Actualización del análisis • Jan 11
CTVA: Planned Seed And Pesticide Split Will Support Future Earnings Power
Analysts lifted their blended fair value estimate for Corteva by about $0.19 to roughly $77.95 per share, reflecting updated price targets that factor in a mixed backdrop for chemicals and agriculture but continued confidence in the company’s ability to increase earnings. Analyst Commentary Recent research on Corteva reflects a mix of optimism and caution, with price targets clustered in the mid to high US$70s and one outlier in the low US$80s.Seeking Alpha • Jan 10
Corteva: Get Your Piece Of SpinCo As A Stable Portfolio Compounder
Summary Corteva is splitting into two pure-play companies, with the seed segment (SpinCo) offering superior stability and margin profile. I rate CTVA a buy, driven by SpinCo's consistent revenue growth, high operating margins (26%), and robust market position in seeds, especially corn. SpinCo trades at an implied 9.3x EV/EBITDA, below sector and CTVA's historical average, with potential for significant buybacks and dividend increases post-separation. Key risk is U.S. isolationism; deteriorating U.S.-China trade could impact corn and soybean sales, potentially altering the investment thesis. Read the full article on Seeking AlphaActualización del análisis • Dec 18
CTVA: Planned Seed And Pesticide Split Will Unlock Future Earnings Power
The analyst price target for Corteva has been nudged higher by approximately $0.05 to about $77.76, as analysts factor in a slightly lower discount rate and modestly improved long term growth expectations, despite broadly cautious sector commentary and recent target reductions. Analyst Commentary Street research on Corteva reflects a divided but generally constructive view, with price targets drifting lower but ratings remaining skewed toward positive as investors reassess the company’s post breakup trajectory and near term earnings backdrop.Actualización del análisis • Dec 03
CTVA: Planned Seed And Pesticide Split Will Unlock Future Earnings Power
Our analyst price target for Corteva has been trimmed modestly in line with recent Street moves, as analysts factor in lower sector multiples and near term earnings uncertainty around the planned split, while still recognizing the company’s intact innovation engine and long term earnings growth potential. Analyst Commentary Street views on Corteva have become more bifurcated following the announced split, with valuation targets reset lower but ratings broadly supportive of the long term strategic rationale and earnings power.Artículo de análisis • Nov 26
A Look At The Fair Value Of Corteva, Inc. (NYSE:CTVA)
Key Insights Corteva's estimated fair value is US$63.85 based on 2 Stage Free Cash Flow to Equity Current share price...Actualización del análisis • Nov 19
CTVA: Upcoming Seed And Pesticide Split Will Unlock Shareholder Value
The analyst consensus price target for Corteva has been modestly reduced, slipping from approximately $77.86 to $77.71. Analysts reflect more cautious expectations for earnings growth in light of a mixed agricultural outlook and anticipated impacts from the company's planned business split.Actualización del análisis • Nov 05
CTVA: Share Split Will Drive Shareholder Value Unlocking Amid Ongoing Business Realignment
Analysts have modestly reduced their average price target for Corteva by approximately $1.20. They cite a more cautious outlook amid challenging crop protection conditions and the company's recent announcement to split into two separate businesses.Actualización del análisis • Oct 22
Analysts Offer Mixed Views as Corteva Eyes Split and Updates Guidance Amid Modest Valuation Shift
Analysts have modestly reduced their price target for Corteva by about $0.76 to $79.05. They cite uncertainty regarding the company’s planned split and the retention of legacy liabilities, though fundamentals and growth remain largely stable.Actualización del análisis • Oct 08
High-Yield Seed Demand And Eco Policies Will Transform Agriculture
Corteva's analyst price target has been modestly reduced by $0.95 per share. Analysts cite continued uncertainty around the planned corporate split and complex crop protection market dynamics.Actualización del análisis • Sep 04
High-Yield Seed Demand And Eco Policies Will Transform Agriculture
Analysts maintained their price target for Corteva at $80.76, citing margin expansion and EBITDA growth driven by successful innovation, favorable market fundamentals, and strong execution. Analyst Commentary Ongoing cost reductions, successful innovation, and strong execution are driving margin expansion and double-digit EBITDA growth.Artículo de análisis • Aug 26
Corteva's (NYSE:CTVA) Shareholders Will Receive A Bigger Dividend Than Last Year
Corteva, Inc. ( NYSE:CTVA ) will increase its dividend from last year's comparable payment on the 15th of September to...Artículo de análisis • Aug 01
Corteva's (NYSE:CTVA) Shareholders Will Receive A Bigger Dividend Than Last Year
Corteva, Inc. ( NYSE:CTVA ) will increase its dividend on the 15th of September to $0.18, which is 5.9% higher than...Artículo de análisis • Jul 28
Investors Interested In Corteva, Inc.'s (NYSE:CTVA) Earnings
With a price-to-earnings (or "P/E") ratio of 43.9x Corteva, Inc. ( NYSE:CTVA ) may be sending very bearish signals at...Artículo de análisis • Jul 14
We Think Corteva (NYSE:CTVA) Can Stay On Top Of Its Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Seeking Alpha • Apr 21
Corteva: Upgraded To Strong Buy On Tariffs, Currency Tailwinds, Strong Guidance
Summary Upgrading Corteva from Buy to Strong Buy due to macro conditions, including tariff-induced supply shocks, rising commodity prices, and currency tailwinds. Corteva's diversified supply chain and local production in seeds position it to benefit from regionalization and potential inflationary pressures in the agricultural sector. Strong Q4 earnings, record operating EBITDA margin, and robust free cash flow support the bullish outlook, with significant shareholder returns through dividends and buybacks. Improved valuation at 20x forward earnings, solid balance sheet, and technical indicators suggest potential for further upside in the current market environment. Read the full article on Seeking AlphaSeeking Alpha • Mar 30
Pure Market Inefficiency In Corteva Preferreds Pricings
Summary This article explores a market inefficiency in fixed-income securities, specifically between Corteva's $4.50 and $3.50 Series Cumulative Preferred Stocks. We identified an arbitrage opportunity due to technical buying, making it an ideal pair trade with identical issues from the same company. On 02/09/2025, we recommended CTA-B for our investment-grade long-duration portfolio. On 02/10/2025, technical high-volume buying in CTA-A turned our initial investment idea into a pair trade. This pair trade highlights how technical factors can create profitable opportunities in fixed-income securities, especially among identical issues from the same issuer. Read the full article on Seeking AlphaSeeking Alpha • Feb 09
CTA.PR.B: An Undervalued Investment-Grade Opportunity From Corteva
Summary CTA-B offers a 6.32% current yield, making it an attractive investment-grade preferred stock with solid financial backing from Corteva, Inc. Corteva, Inc.'s strong financial health and low leverage ensure the safety of uninterrupted dividend distributions for CTA-B shareholders. Comparative analysis shows CTA-B is undervalued, offering a potential 10% capital appreciation relative to its peers and Corteva's OTC bonds. Corteva's BBB credit rating and low-risk perception in the bond market further reinforce the security and value of investing in CTA-B. Read the full article on Seeking AlphaSeeking Alpha • Jan 10
Corteva: A Wide-Moat Play On Commodity Prices
Summary Corteva is a strong defensive play for stagflation with its wide economic moat in seeds, providing exposure to agricultural commodities and a growing dividend. The company has shown impressive performance since its 2019 spin-off, with growth in gross profits and operating income exceeding revenue growth, reflecting strong operating efficiency. Corteva faces risks such as regulatory and ESG concerns, pricing pressure in crop protection, and currency fluctuations, but remains a resilient and diversified investment. I rate Corteva a "Buy" for its defensive characteristics, allowing investors to gain commodity exposure as a best-in-breed operator. Read the full article on Seeking AlphaSeeking Alpha • Nov 10
Corteva Q3: Lower Commodity And Raw Material Costs Ahead, Potential Margin Expansion
Summary I reiterate a 'Buy' rating for Corteva with a fair value target of $68 per share, driven by anticipated margin expansion and end-market recovery. Corteva's Q3 results showed weak growth in Latin America, but benefits from raw material cost deflation and cost management are expected to enhance margins in FY25. Management forecasts a flat crop protection market for FY25, with significant cost reductions from lower seed commodity costs and deflationary raw materials. Despite near-term price/mix challenges, lower input costs could be a major catalyst for margin expansion, supporting the stock's undervaluation and 'Buy' recommendation. Read the full article on Seeking AlphaDesglose de ingresos y gastos
Desglose de ingresos y gastos
Cómo gana y gasta dinero Corteva. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 26 | 17,889 | 1,252 | 3,628 | 1,480 |
| 31 Dec 25 | 17,401 | 1,193 | 3,515 | 1,474 |
| 30 Sep 25 | 17,469 | 1,681 | 3,420 | 1,426 |
| 30 Jun 25 | 17,177 | 1,469 | 3,397 | 1,423 |
| 31 Mar 25 | 16,833 | 1,142 | 3,325 | 1,405 |
| 31 Dec 24 | 16,908 | 851 | 3,340 | 1,402 |
| 30 Sep 24 | 16,637 | 670 | 3,333 | 1,394 |
| 30 Jun 24 | 16,901 | 874 | 3,325 | 1,381 |
| 31 Mar 24 | 16,834 | 698 | 3,318 | 1,353 |
| 31 Dec 23 | 17,226 | 929 | 3,295 | 1,337 |
| 30 Sep 23 | 17,344 | 1,119 | 3,303 | 1,320 |
| 30 Jun 23 | 17,531 | 1,112 | 3,238 | 1,297 |
| 31 Mar 23 | 17,738 | 1,234 | 3,099 | 1,264 |
| 31 Dec 22 | 17,455 | 1,205 | 3,010 | 1,216 |
| 30 Sep 22 | 17,109 | 1,401 | 2,706 | 1,192 |
| 30 Jun 22 | 16,703 | 1,760 | 2,417 | 1,177 |
| 31 Mar 22 | 16,078 | 1,776 | 2,143 | 1,174 |
| 31 Dec 21 | 15,655 | 1,812 | 1,891 | 1,187 |
| 30 Sep 21 | 15,383 | 1,756 | 2,055 | 1,176 |
| 30 Jun 21 | 14,875 | 1,330 | 2,213 | 1,163 |
| 31 Mar 21 | 14,439 | 1,075 | 2,417 | 1,143 |
| 31 Dec 20 | 14,217 | 736 | 2,675 | 1,142 |
| 30 Sep 20 | 13,993 | 594 | 2,744 | 1,127 |
| 30 Jun 20 | 14,041 | 470 | 2,839 | 1,132 |
| 31 Mar 20 | 14,406 | 179 | 2,856 | 1,128 |
| 31 Dec 19 | 13,846 | -288 | 2,874 | 1,147 |
| 30 Sep 19 | 13,678 | -1,322 | 2,797 | 1,202 |
| 30 Jun 19 | 13,714 | -6,453 | 2,764 | 1,238 |
| 31 Mar 19 | 12,921 | -6,965 | 2,662 | 1,312 |
| 31 Dec 18 | 14,287 | -6,813 | 2,766 | 1,355 |
| 30 Sep 18 | 14,299 | -3,538 | 2,786 | 1,393 |
| 30 Jun 18 | 14,220 | 1,261 | 2,888 | 1,455 |
| 31 Mar 18 | 14,230 | 1,898 | 2,930 | 1,482 |
| 31 Dec 17 | 10,684 | 2,081 | 3,082 | 1,075 |
| 31 Dec 16 | 14,041 | 503 | 2,937 | 1,507 |
Ingresos de calidad: CTVA tiene una única gran pérdida de $870.0M que afecta a sus resultados financieros de los últimos 12 meses de 31st March, 2026.
Margen de beneficios creciente: Los actuales márgenes de beneficio (7%) de CTVA son superiores a los del año pasado (6.8%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de CTVA han disminuido en un 6.6% al año en los últimos 5 años.
Acelerando crecimiento: El crecimiento de los beneficios de CTVA en el último año (9.6%) supera su media de 5 años (-6.6% al año).
Beneficios vs. Industria: El crecimiento de los beneficios de CTVA en el último año (9.6%) superó al de la industria Chemicals 0.7%.
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de CTVA (5.1%) se considera baja.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/11 11:38 |
| Precio de las acciones al final del día | 2026/05/11 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Corteva, Inc. está cubierta por 39 analistas. 19 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| null null | Argus Research Company |
| Benjamin Theurer | Barclays |
| Benjamin Theurer | Barclays |